| Lab Tests | CBC: 9-Jul-2024: RBC: 3.6*1012/L; HGB: 121 g/L; PLT: 183*109/L; WBC: 6.7*109/L; NEU: 75%; EOS: 1%; BAS: 1%; LYM: 23%; ESR: 24 mm/hour. Biochemistry: 9-Jul-2024: Total bilirubin: 18 μmol/L; Direct bilirubin: 8 μmol/L; Urea: 5.6 μmol/L; Total protein: 70 g/L; Creatinine: 104 μmol/L, ALAT: 22 U/L; ASAT: 28 U/L; Glucose: 4.1 mmol/L; Total cholesterol: 4.4 mmol/L; LDL: 2.4 mmol/L; HDL: 2.4 mmol/L |
| N (Node) | cN1 |
| Treatment of Concomitant Diseases | No |
| M (Metastasis) | cM1 |
| Date of diagnosis | 2024/6/21 |
| Drinking History | Non-drinker |
| Biomarkers | 21-Jun-2024: ER negative; PR negative; Her2 negative; Ki-67 50% |
| Race | Caucasian |
| Stage of disease | IV |
| Height, cm | |
| Treatment | Not treated |
| Date of Draw | 2024/7/9 |
| Processing | Single spin |
| Weight, kg | 76 |
| Concomitant Diseases | No |
| Pathology Report | Invasive carcinoma of no special type (NST) of the right breast, tumor size: 6.2 cm x 5.3 cm x 6.6 cm. Mts: axillary lymph nodes; Lungs, liver. |
| Grade | G2 |
| COVID-19 Vaccination | Vaccinated: Pfizer |
| Clinical diagnosis | TNBC: Invasive carcinoma of no special type (NST) |
| T (Tumor) | cT4 |
| HIV, HBV, HCV, RPR | Negative |
| Location Country | Ukraine |
| Smoking History | Non-smoker |
| Cancer History and Relapses | No |
